Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
UKTraining

F52 Impact of the EU Regulation (536/2014)


Add this event to your calendar: iCal   Google Calendar

Who should attend?

Clinical researchers with at least one year of experience, who wish to explore the impact and wider application of the new EU Regulation for Clinical Trials on their current practices.

Details

The 2001 Clinical Trials Directive (2001/20/EC) has been criticised by patients, researchers and industry alike for its disproportionate regulatory requirements. High costs and a lack of harmonisation of the applicable rules necessary for multinational clinical trials have contributed to a significant decline in the number of clinical trials in the EU – a reduction of about 25% in the last few years.
The new EU Clinical Trials Regulation is due to be enacted in 2016 and will replace the 2001 Clinical Trials Directive (CTD) (2001/20/EC). The Regulation aims to restore the EU’s competitiveness in clinical research and the development of new and innovative treatments and medicines by cutting red-tape and bringing patient-oriented research back to Europe.


The regulation includes rules for clinical trials which are conducted outside the EU but referred to in a clinical trial application within the EU. For such trials, the rules call for compliance with regulatory requirements at least equivalent to those in the EU, including rules on transparency.


In this highly interactive course, we explore the changes proposed by the regulation and how they will impact our current practices in conducting global clinical trials.


• Distinguish between a Regulation and a Directive
• Identify what will change under Regulation 536/2014
• Identify what will not change under Regulation 536/2014
• Define Low-Impact Interventional Trials
• Discuss the impact on
      – Application processes
      – Informed consent
      – Transparency requirements
• Describe next steps for implementation of Regulation 536/2014

Prices

ICR Member - 450GBP (credit card 463.50GBP) ICR Member (Academic/Freelance) - 350GBP (credit card 360.50GBP) Guest - 550GBP (credit card 566.50GBP)

Contact

Jo Hall
office@icr-global.org

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.